Medication in lower doses can save the healthcare system billions of DKK
The effect of cancer drugs can often be preserved even when the labeled dose is significantly reduced. This can be used to spare cancer patients from side effects, free up staffing resources, and save the Danish healthcare system billions of DKK annually. This is the assessment of BRIC group leader and senior physician Kim Theilgaard-Mönch and Director of Nordic Institute of Health Economics Lars Holger Ehlers, who have been involved in developing a concept that will secure these major benefits.
Read more in Hæmatologisk Tidsskrift (in Danish)
Read more in Dagens Medicin (in Danish)
Read original paper in Nature Reviews Clinical Oncology:
Dose-reduction trials in oncology — aiming for less toxicity and better quality of life at lower costs